SG10201600336RA - A novel surface exposed haemophilus influenzae protein (protein e; pe) - Google Patents

A novel surface exposed haemophilus influenzae protein (protein e; pe)

Info

Publication number: SG10201600336RA
Authority: SG; Singapore
Prior art keywords: protein; surface exposed; haemophilus influenzae; novel surface; exposed haemophilus
Prior art date: 2006-01-17

Application number

SG10201600336RA

Inventor

Arne Forsgren

Kristian Riesbeck

Original Assignee

Arne Forsgren

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-17

Filing date

2007-01-17

Publication date

2016-02-26

2007-01-17 Application filed by Arne Forsgren filed Critical Arne Forsgren

2016-02-26 Publication of SG10201600336RA publication Critical patent/SG10201600336RA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/012—Coccidia antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SG10201600336RA 2006-01-17 2007-01-17 A novel surface exposed haemophilus influenzae protein (protein e; pe) SG10201600336RA (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US75898706P	2006-01-17	2006-01-17

Publications (1)

Publication Number	Publication Date
SG10201600336RA true SG10201600336RA (en)	2016-02-26

Family

ID=38287906

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG10201600336RA SG10201600336RA (en)	2006-01-17	2007-01-17	A novel surface exposed haemophilus influenzae protein (protein e; pe)
SG2011003233A SG175492A1 (en)	2006-01-17	2007-01-17	A novel surface exposed haemophilus influenzae protein (protein e; pe)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG2011003233A SG175492A1 (en)	2006-01-17	2007-01-17	A novel surface exposed haemophilus influenzae protein (protein e; pe)

Country Status (20)

Country	Link
US (5)	US8617565B2 (en)
EP (1)	EP1973933B1 (en)
JP (3)	JP5275814B2 (en)
KR (2)	KR20080096775A (en)
CN (2)	CN101374859B (en)
AU (1)	AU2007206114B2 (en)
BR (1)	BRPI0707154B8 (en)
CA (1)	CA2636566C (en)
EA (1)	EA015561B1 (en)
ES (1)	ES2809167T3 (en)
IL (2)	IL192674B (en)
MA (1)	MA30309B1 (en)
MX (1)	MX2008009280A (en)
MY (1)	MY150105A (en)
NO (1)	NO346497B1 (en)
NZ (1)	NZ569417A (en)
SG (2)	SG10201600336RA (en)
UA (1)	UA92782C2 (en)
WO (1)	WO2007084053A1 (en)
ZA (1)	ZA200805602B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0410866D0 (en)	2004-05-14	2004-06-16	Chiron Srl	Haemophilius influenzae
JP5269594B2 (en)	2005-08-10	2013-08-21	アルネ・フオシユグレン・アー・ベー	Interaction of Moraxella catarrhalis with epithelial cells, extracellular matrix proteins and complement system
SG10201600336RA (en) *	2006-01-17	2016-02-26	Arne Forsgren	A novel surface exposed haemophilus influenzae protein (protein e; pe)
TW201302779A (en) *	2011-04-13	2013-01-16	Glaxosmithkline Biolog Sa	Fusion proteins & combination vaccines
EA201391669A1 (en) *	2011-05-11	2014-04-30	Риесбекк Хелткеэр Свиден Аб	PROTEIN F - NEW ADHESIN HAEMOPHILUS INFLUENZAE, THE CAPABLE TO BIND LAMININ AND VITRONECTIN
CN104968366B (en) *	2012-10-17	2017-12-01	葛兰素史密丝克莱恩生物有限公司	The immunogenic composition of protein component comprising one or more pneumoniae capsular conjugates and containing albumen E and/or PilA from haemophilus influenzae
GB201218660D0 (en)	2012-10-17	2012-11-28	Glaxosmithkline Biolog Sa	Immunogenic composition
TW201620927A (en) *	2014-02-24	2016-06-16	葛蘭素史密斯克藍生物品公司	USPA2 protein constructs and uses thereof
CN105175549B (en) *	2015-09-30	2019-08-16	康希诺生物股份公司	A kind of haemophilus influenzae fusion protein and its construction method and application
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
WO2018178265A1 (en)	2017-03-31	2018-10-04	Glaxosmithkline Intellectual Property Development Limited	Immunogenic composition, use and method of treatment
US11167022B2 (en)	2017-03-31	2021-11-09	Glaxosmithkline Intellectual Property Development Limited	Immunogenic composition, use and method of treatment
JP7291633B2 (en)	2017-05-30	2023-06-15	グラクソスミスクラインバイオロジカルズソシエテアノニム	Method for manufacturing an adjuvant
MX2020001820A (en)	2017-08-14	2020-03-20	Glaxosmithkline Biologicals Sa	Methods of boosting immune responses.
CN111670044A (en)	2017-12-01	2020-09-15	葛兰素史密丝克莱恩生物有限公司	Purification of saponins
CN108037277A (en) *	2017-12-07	2018-05-15	中国兽医药品监察所	It is a kind of to distinguish Brucella abortus vaccine immunity and the method for natural infection state
WO2020030572A1 (en)	2018-08-07	2020-02-13	Glaxosmithkline Biologicals Sa	Processes and vaccines
US20220339282A1 (en)	2018-11-29	2022-10-27	Glaxosmithkline Biologicals Sa	Methods for manufacturing an adjuvant
JP2022526434A (en) *	2019-04-12	2022-05-24	ジェルター，インコーポレイテッド	Recombinant elastin and its production
WO2020245207A1 (en)	2019-06-05	2020-12-10	Glaxosmithkline Biologicals Sa	Saponin purification
WO2021023691A1 (en)	2019-08-05	2021-02-11	Glaxosmithkline Biologicals Sa	Immunogenic composition
WO2021023692A1 (en)	2019-08-05	2021-02-11	Glaxosmithkline Biologicals Sa	Process for preparing a composition comprising a protein d polypeptide
WO2022175423A1 (en)	2021-02-22	2022-08-25	Glaxosmithkline Biologicals Sa	Immunogenic composition, use and methods
WO2024017827A1 (en)	2022-07-19	2024-01-25	Glaxosmithkline Biologicals Sa	Continuous process for vaccine production

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4946778A (en)	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
US5173294A (en)	1986-11-18	1992-12-22	Research Foundation Of State University Of New York	Dna probe for the identification of haemophilus influenzae
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE68929323T2 (en)	1988-12-16	2002-04-18	De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur	PNEUMOLYSIN MUTANTS AND PNEUMOCOCCAL VACCINES THEREOF
SE466259B (en)	1990-05-31	1992-01-20	Arne Forsgren	PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
GB9022190D0 (en)	1990-10-12	1990-11-28	Perham Richard N	Immunogenic material
US5843463A (en) *	1990-12-21	1998-12-01	Antexbiologics, Inc.	Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US6592876B1 (en)	1993-04-20	2003-07-15	Uab Research Foundation	Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US5476929A (en)	1991-02-15	1995-12-19	Uab Research Foundation	Structural gene of pneumococcal protein
JP3215109B2 (en)	1991-02-15	2001-10-02	ユーエイビーリサーチファウンデーション	Structural gene of pneumococcal protein
US5552146A (en)	1991-08-15	1996-09-03	Board Of Regents, The University Of Texas System	Methods and compositions relating to useful antigens of Moraxella catarrhalis
WO1994000153A1 (en)	1992-06-25	1994-01-06	Smithkline Beecham Biologicals (S.A.)	Vaccine composition containing adjuvants
WO1994005311A1 (en)	1992-08-27	1994-03-17	Deakin Research Limited	Retro-, inverso-, and retro-inverso synthetic peptide analogues
GB9224584D0 (en)	1992-11-23	1993-01-13	Connaught Lab	Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
KR100310510B1 (en)	1993-03-23	2002-07-04	장 스테판느	Vaccine composition containing 3-0-deacetylated monophosphoryl lipid A
US5747292A (en)	1993-04-06	1998-05-05	Fred Hutchinson Cancer Research Center	Chimeric cytokine receptors in lymphocytes
ATE226831T1 (en)	1993-05-18	2002-11-15	Univ Ohio State Res Found	VACCINE AGAINST ENTIRE EAR INFLAMMATION
AU683073B2 (en)	1993-06-07	1997-10-30	Amgen, Inc.	Hybrid receptor molecules
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
FR2717081B1 (en)	1994-03-14	1996-06-21	Centre Nat Rech Scient	Retropeptides, antibodies to the latter, and their uses for vaccination and in vitro diagnosis.
DE69535036T3 (en)	1994-07-15	2011-07-07	The University of Iowa Research Foundation, IA	IMMUNOMODULATIVE OLIGONUCLEOTIDES
US5565204A (en)	1994-08-24	1996-10-15	American Cyanamid Company	Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
UA56132C2 (en)	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine
US6440425B1 (en)	1995-05-01	2002-08-27	Aventis Pasteur Limited	High molecular weight major outer membrane protein of moraxella
US5843464A (en)	1995-06-02	1998-12-01	The Ohio State University	Synthetic chimeric fimbrin peptides
PL323781A1 (en)	1995-06-07	1998-04-27	Biochem Vaccines Inc	Streptococco thermal shock proteins belonging to a family hsp70
GB9513074D0 (en)	1995-06-27	1995-08-30	Cortecs Ltd	Novel anigen
US6290970B1 (en)	1995-10-11	2001-09-18	Aventis Pasteur Limited	Transferrin receptor protein of Moraxella
US6090576A (en)	1996-03-08	2000-07-18	Connaught Laboratories Limited	DNA encoding a transferrin receptor of Moraxella
ES2262177T3 (en)	1996-05-01	2006-11-16	The Rockefeller University	PROTEINS OF UNION TO HILL FOR VACCINES AGAINST NEUMOCOCOS.
US7341727B1 (en)	1996-05-03	2008-03-11	Emergent Product Development Gaithersburg Inc.	M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
US5882896A (en)	1996-09-24	1999-03-16	Smithkline Beecham Corporation	M protein
US5882871A (en)	1996-09-24	1999-03-16	Smithkline Beecham Corporation	Saliva binding protein
ATE479756T1 (en)	1996-10-31	2010-09-15	Human Genome Sciences Inc	STREPTOCOCCUS PNEUMONIAE ANTIGENS AND VACCINES
CA2292838A1 (en)	1997-06-03	1998-12-10	Connaught Laboratories Limited	Lactoferrin receptor genes of moraxella
HUP0002475A3 (en)	1997-07-21	2002-01-28	Baxter Healthcare S A Wallisel	Modified immunogenic pneumolysin compositions as vaccines
NZ530277A (en)	1998-04-07	2005-08-26	Medimmune Inc	Derivatives of pneumococcal choline binding proteins for vaccines
WO1999053940A1 (en)	1998-04-23	1999-10-28	Uab Research Foundation	PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
GB9812613D0 (en)	1998-06-11	1998-08-12	Smithkline Beecham Biolog	Vaccine
TR200102735T2 (en) *	1999-03-19	2002-04-22	Smithkline Beecham Biologicals S.A.	Vaccine.
GB9918319D0 (en)	1999-08-03	1999-10-06	Smithkline Beecham Biolog	Vaccine composition
GB0003502D0 (en)	2000-02-15	2000-04-05	Smithkline Beecham Sa	Vaccine
AU8189501A (en) *	2000-06-29	2002-01-08	Smithkline Beecham Biolog	Vaccine composition
EP2280071A3 (en)	2000-10-02	2011-04-27	ID Biomedical Corporation	Haemophilus influenzae antigens and corresponding DNA fragments
GB0025171D0 (en)	2000-10-13	2000-11-29	Smithkline Beecham Biolog	Novel compounds
GB0025170D0 (en)	2000-10-13	2000-11-29	Smithkline Beecham Biolog	Novel compounds
GB0025998D0 (en)	2000-10-24	2000-12-13	Smithkline Beecham Biolog	Novel compounds
GB0410866D0 (en) *	2004-05-14	2004-06-16	Chiron Srl	Haemophilius influenzae
SG10201600336RA (en)	2006-01-17	2016-02-26	Arne Forsgren	A novel surface exposed haemophilus influenzae protein (protein e; pe)
US9473463B2 (en)	2014-07-29	2016-10-18	Combined Conditional Access Development & Support, LLC	Control word and associated entitlement control message caching and reuse

2007
- 2007-01-17 SG SG10201600336RA patent/SG10201600336RA/en unknown
- 2007-01-17 SG SG2011003233A patent/SG175492A1/en unknown
- 2007-01-17 ZA ZA200805602A patent/ZA200805602B/en unknown
- 2007-01-17 KR KR1020087020155A patent/KR20080096775A/en not_active Application Discontinuation
- 2007-01-17 MX MX2008009280A patent/MX2008009280A/en active IP Right Grant
- 2007-01-17 AU AU2007206114A patent/AU2007206114B2/en not_active Ceased
- 2007-01-17 ES ES07701118T patent/ES2809167T3/en active Active
- 2007-01-17 CA CA2636566A patent/CA2636566C/en active Active
- 2007-01-17 NZ NZ569417A patent/NZ569417A/en not_active IP Right Cessation
- 2007-01-17 WO PCT/SE2007/000034 patent/WO2007084053A1/en active Application Filing
- 2007-01-17 NO NO20082827A patent/NO346497B1/en unknown
- 2007-01-17 EA EA200870176A patent/EA015561B1/en unknown
- 2007-01-17 CN CN200780003278.2A patent/CN101374859B/en active Active
- 2007-01-17 EP EP07701118.7A patent/EP1973933B1/en active Active
- 2007-01-17 US US12/161,040 patent/US8617565B2/en active Active
- 2007-01-17 MY MYPI20082409A patent/MY150105A/en unknown
- 2007-01-17 JP JP2008551220A patent/JP5275814B2/en not_active Expired - Fee Related
- 2007-01-17 KR KR1020147017243A patent/KR101737464B1/en active IP Right Grant
- 2007-01-17 UA UAA200810445A patent/UA92782C2/en unknown
- 2007-01-17 CN CN201410569401.9A patent/CN104436180B/en active Active
- 2007-01-17 BR BRPI0707154A patent/BRPI0707154B8/en not_active IP Right Cessation
2008
- 2008-07-07 IL IL192674A patent/IL192674B/en active IP Right Grant
- 2008-08-12 MA MA31171A patent/MA30309B1/en unknown
2013
- 2013-01-17 JP JP2013006549A patent/JP6008747B2/en not_active Expired - Fee Related
- 2013-11-20 US US14/085,007 patent/US20150071956A1/en not_active Abandoned
- 2013-12-17 US US14/109,573 patent/US9309293B2/en active Active
2015
- 2015-10-30 US US14/929,011 patent/US9744225B2/en active Active
2016
- 2016-01-07 JP JP2016001727A patent/JP2016135770A/en active Pending
2017
- 2017-07-26 US US15/660,455 patent/US11400148B2/en active Active
2018
- 2018-05-13 IL IL259316A patent/IL259316B2/en unknown

Also Published As

Publication number	Publication date
NO20082827L (en)	2008-10-17
ZA200805602B (en)	2009-12-30
EP1973933A1 (en)	2008-10-01
US20170326223A1 (en)	2017-11-16
NZ569417A (en)	2012-04-27
BRPI0707154B1 (en)	2019-05-07
JP2016135770A (en)	2016-07-28
CA2636566C (en)	2018-03-13
US20090246219A1 (en)	2009-10-01
JP2009523790A (en)	2009-06-25
US20140350220A1 (en)	2014-11-27
AU2007206114B2 (en)	2013-01-24
MY150105A (en)	2013-11-29
SG175492A1 (en)	2011-11-28
EP1973933B1 (en)	2020-06-24
JP2013126986A (en)	2013-06-27
AU2007206114A1 (en)	2007-07-26
EP1973933A4 (en)	2010-04-07
EA015561B1 (en)	2011-08-30
US8617565B2 (en)	2013-12-31
CA2636566A1 (en)	2007-07-26
IL259316A (en)	2018-07-31
CN104436180A (en)	2015-03-25
BRPI0707154B8 (en)	2022-12-20
UA92782C2 (en)	2010-12-10
MA30309B1 (en)	2009-04-01
IL259316B2 (en)	2023-02-01
ES2809167T3 (en)	2021-03-03
US9744225B2 (en)	2017-08-29
IL259316B (en)	2022-10-01
KR101737464B1 (en)	2017-05-18
KR20080096775A (en)	2008-11-03
US20150071956A1 (en)	2015-03-12
MX2008009280A (en)	2008-12-12
EA200870176A1 (en)	2009-06-30
US11400148B2 (en)	2022-08-02
JP5275814B2 (en)	2013-08-28
KR20140101387A (en)	2014-08-19
IL192674B (en)	2018-08-30
US9309293B2 (en)	2016-04-12
IL192674A0 (en)	2009-02-11
CN101374859A (en)	2009-02-25
CN101374859B (en)	2014-11-26
US20160114021A1 (en)	2016-04-28
JP6008747B2 (en)	2016-10-19
WO2007084053A1 (en)	2007-07-26
CN104436180B (en)	2021-08-31
BRPI0707154A2 (en)	2011-04-26
NO346497B1 (en)	2022-09-05

Publication	Publication Date	Title
IL259316B (en)	2022-10-01	A novel surface exposed haemophilus influenzae protein (protein e; pe)
EP1871888A4 (en)	2013-08-21	Haemophilus influenzae type b
EP2030015A4 (en)	2009-11-11	Protein surface remodeling
EP2088891A4 (en)	2011-02-16	Connector for stick
GB2457393B (en)	2011-09-07	A connector means
IL194165A0 (en)	2011-08-01	Glycosylated antibodies
PL2423315T3 (en)	2015-06-30	A method for achieving improved polypeptide expression
ZA200808179B (en)	2010-03-31	Sensor interface
ZA200904317B (en)	2010-08-25	Improved method for making analgesics
IL196889A0 (en)	2011-08-01	Albumin-insulin fusion proteins
EP1991565A4 (en)	2009-12-09	Shiga toxoid chimeric proteins
IL196496A (en)	2016-05-31	Method for producing a recombinant protein
GB0623517D0 (en)	2007-01-03	A connector
EP2002400A4 (en)	2014-10-15	Virtual view schematic editor
EP2066601A4 (en)	2010-02-17	Hydrosilylation
IL197022A0 (en)	2009-11-18	Novel preparation method
GB0612443D0 (en)	2006-08-02	Protein
GB0620304D0 (en)	2006-11-22	Protein
GB0600975D0 (en)	2006-03-01	Connecting duvet
GB0617221D0 (en)	2006-10-11	Creative process
GB0624890D0 (en)	2007-01-24	A protein involved in protein
GB0607100D0 (en)	2006-05-17	Protein production
GB0616968D0 (en)	2006-10-04	Protein
GB0616971D0 (en)	2006-10-04	Protein
GB0616970D0 (en)	2006-10-04	Protein